Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
David Matthew
David Matthew Deaven, Delafield, WI US
| Patent application number | Description | Published |
|---|---|---|
| 20080232701 | Content-based image compression - A technique for selecting portions of a multi-resolution medical image data set to be stored and the portions of the multi-resolution medical image data set to be discarded in order to reduce the overall amount of image data that is stored for each image data set. The selection is based on the clinical purpose for obtaining the medical image data. The clinical purpose for obtaining the medical image is used to select a segmentation algorithm to segment the image data into several regions based on their relevance to the purpose for obtaining the image data. A mask is created from the segmented data. The mask is used to assign data compression quality factors to corresponding regions in the image data. The image data in each region is compressed based on their assigned quality factor. The image data that is highly relevant is compressed with lossless data compression. The image data in regions of lesser relevance are compressed with lossy data compression. The image data that is of no relevance for the purpose that the image data was obtained is discarded. | 09-25-2008 |
| 20090040565 | SYSTEMS, METHODS AND APPARATUS FOR HEALTHCARE IMAGE RENDERING COMPONENTS - Systems, methods and apparatus are provided through which in some embodiments healthcare graphical image annotation classes are extensions of a standard user interface class. | 02-12-2009 |
David Matthew Pier, Ipswich GB
| Patent application number | Description | Published |
|---|---|---|
| 20110256109 | CHONDROGENIC PROGENITOR CELLS, PROTOCOL FOR DERIVATION OF CELLS AND USES THEREOF - The present invention provides an isolated population of chondrocyte precursor cells wherein 1% or less of the cells express Oct4, Nanog and/or TRA-1-60, 7% or less of the cells express no collagen II, collagen X, CD105 or Stro-1 and 85% or more of the cells express CBFA1, methods for preparing such cells and uses of chondrocyte cells derived from said precursor cells. | 10-20-2011 |
David Matthew Smith, Fife GB
| Patent application number | Description | Published |
|---|---|---|
| 20120041241 | OLIGOMERISATION OF OLEFINIC COMPOUNDS IN THE PRESENCE OF AN ACTIVATED OLIGOMERISATION CATALYST - This invention relates to the oligomerisation of olefinic compounds in the presence of an activated oligomerisation catalyst. The invention also extends to a particular manner for providing an activated oligomerisation catalyst. According to the present invention, there is provided a process for producing an oligomeric product by the oligomerisation of at least one olefinic compound, the process including (a) providing an activated oligomerisation catalyst by combining, in any order, iii) a source of chromium, ιv) a ligating compound of the formula (R | 02-16-2012 |
David Matthew Strei, Waconia, MN US
| Patent application number | Description | Published |
|---|---|---|
| 20110053526 | WIRELESS PROCESS COMMUNICATION ADAPTER WITH IMPROVED ENCAPSULATION - A wireless process communication adapter for field devices is provided. The adapter includes a metal housing having a first end and a second end. A chamber is defined between the first and second ends. A radio-frequency transparent radome is coupled to the first end. The second end has a field device coupling configured to attach to a field device. At least one circuit board is disposed within the chamber. The circuit board supports at least wireless process communication circuitry. A plurality of wires is coupled to the at least one circuit board and extends through the field device coupling. A silicone potting fills substantially all volume within the chamber not occupied by the at least one circuit board and wireless process communication circuitry. | 03-03-2011 |
David Matthew Tarlinton, Victoria AU
| Patent application number | Description | Published |
|---|---|---|
| 20100087436 | METHOD OF PREVENTING OR TREATING ORGAN, HEMATOPOIETIC STEM CELL OR BONE MARROW TRANSPLANT REJECTION - Methods of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection are disclosed. | 04-08-2010 |
David Matthew Thompson, West Midlands GB
| Patent application number | Description | Published |
|---|---|---|
| 20080264498 | Valve with Sensor - A valve is provided according to one embodiment of the invention. The valve comprises a piston ( | 10-30-2008 |
David Matthew West, Fremont, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080281641 | SYSTEM AND METHOD FOR ADMINISTERING A GROUP BENEFIT PLAN - A system and method for administering a group benefits plan having a processor configured to receive data for enrolling a participant in a group benefits plan self-administered by an employer, receive a claim submission for the participant, transmit the claim submission to a plan supervisor terminal for review, and receive electronic notification to deny or reimburse the participant's claim submission. | 11-13-2008 |
David Matthew Wilson, Hertfordshire GB
| Patent application number | Description | Published |
|---|---|---|
| 20090306052 | INDENYL DERIVATIVES AND USE THEREOF FOR THE TREATMENT OF NEUROLOGICAL DISORDERS - The present invention relates to novel indenyl derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders. | 12-10-2009 |
David Matthew Wilson, Essex GB
| Patent application number | Description | Published |
|---|---|---|
| 20080275027 | Piperazinone Derivatives Useful as Histamine H3 Receptor Antagonists and/or Inverse Agonists - The invention relates to compounds of formula (I) or salts and solvates thereof, processes for their preparation, to compositions containing them and to their use in the treatment of various disorders, such as allergic rhinitis: | 11-06-2008 |
| 20090105217 | 2-PHENYL-5-AMINO-1,3,4-OXADIAZOLES AND THEIR USE AS NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS - Novel oxadiazole derivatives of formula (I) having pharmacological activity, processes for their preparation, compositions containing them and their use in the treatment of neurological, psychiatric disorders and gastrointestinal disorders through modulation of the nicotinic α7 receptor. | 04-23-2009 |
David Matthew Wilson, Harlow Essex GB
| Patent application number | Description | Published |
|---|---|---|
| 20080207638 | Compounds - The present invention relates to compounds of formula (I), | 08-28-2008 |
David Matthew Wilson, Harlow GB
| Patent application number | Description | Published |
|---|---|---|
| 20090105226 | BENZAZEPINE DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS - The present invention relates to novel benzazepine derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders. | 04-23-2009 |
| 20100075953 | SUBSTITUTED PIPERAZINES, (1,4) DIAZEPINES, AND 2,5-DIAZABICYCLO (2.2.1) HEPTANES AS HISTAMINE H1 AND/OR H3 ANTAGONISTS OR HISTAMINE H3 REVERSE ANTAGONISTS - The present invention relates to novel piperazine and azepine derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurodegenerative disorders including Alzheimer's disease. | 03-25-2010 |
| 20100145040 | Benzazepine Derivatives For The Treatment of Neurological Disorders - The present invention relates to novel benzazepine derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders. | 06-10-2010 |
David Matthew Withall, Oxford GB
| Patent application number | Description | Published |
|---|---|---|
| 20120040953 | Compounds for the Treatment of Metabolic Disorders - The present invention is directed to therapeutic compounds which have activity as agonists of GPR119 and are useful for the treatment of metabolic disorders including type II diabetes. | 02-16-2012 |
David Matthew Zasada, Taberg, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20090091492 | Detection and mitigation radio frequency memory (DRFM)-based interference in synthetic aperture radar (SAR) images - Methods and systems for detecting and mitigating DRFM-based interference in SAR images are provided. Embodiments include methods and systems for detecting and removing DRFM-based interference from SAR images by exploiting multi-channel SAR data. Embodiments provide an Electronic Counter Counter Measure (ECCM) technique that is effective against, among others, SAR DRFM-based repeater jamming, false target images, noise jamming, and vector multiplier jamming for false scene generation. When used, embodiments of the present invention reduce jammer effectiveness to a small range strip (a strip parallel to the range dimension) in the direction of the jammer. In addition, jammer mitigation is performed without losing SAR image data at the affected SAR pixels. Furthermore, embodiments of are compatible with time variable ECCM techniques, including orthogonal waveforms or pulse jitter techniques, for example. | 04-09-2009 |
| 20090128401 | SYSTEM AND METHOD FOR MONITORING TARGETS - A system comprising a moving radar, a processing device, and a phase difference determination device is used to monitor a target. The moving radar has first and second phase centers that transmit and receive signals normal to a direction of movement of the radar. The processing device receives first and second ones of the received signals from the first and second phase centers, respectively, and performs a target motion compensation and target acceleration correction for each of the first and second received signals to produce first and second images. The phase difference determination device determines a phase difference image from a comparison of the first and second images. | 05-21-2009 |
David Matthew Zeanah, Knoxville, TN US
| Patent application number | Description | Published |
|---|---|---|
| 20100122925 | SYRINGE DISPOSAL UNIT - This invention presents a syringe disposal unit for disposal of used disposable syringe needle assemblies of a reusable syringe. The syringe disposal includes a container having an interior for receiving a needle assembly of a reusable syringe. The needle assembly is removable from a syringe body of the reusable syringe. The container also has a through-hole through which the needle assembly can enter the interior. The syringe disposal also includes a needle base latch movable between an engaging position and a disengaging position. When the needle assembly is positioned in the through-hole the needle base latch contacts the needle assembly in the engaging position in such a way that the needle base latch prevents the needle assembly from rotating relative to the container, while the needle base latch does not contact the needle assembly in the disengaging position in such a manner that the needle base latch does not prevent the needle base from rotating relative to the container. | 05-20-2010 |